Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
11
LENZ Quote, Financials, Valuation and Earnings
Last price:
$17.14
Seasonality move
:
-5.91%
Day range:
$16.26 - $17.46
52-week range:
$15.70 - $50.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
26.94x
P/B ratio:
2.73x
Volume:
810.9K
Avg. volume:
1.2M
1-year change:
-46.04%
Market cap:
$528.5M
Revenue:
--
EPS (TTM):
-$2.11
Earnings Data
Next earnings date for LENZ
Mar 18
2026
Most recent earnings per share
-$0.59
Beat by $0.10
(Nov 5/2025)
Consensus Estimate
-$0.69
(Nov 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
LENZ Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/18/2026 | Q4 | $1.5M | -- | -- | -$0.96 | -- |
| 11/05/2025 | Q3 | $4.6M | $12.5M | -$0.59 | -$0.69 | $0.10 |
| 07/30/2025 | Q2 | $714.3K | $5M | -$0.53 | -$0.54 | $0.01 |
| 05/08/2025 | Q1 | -- | -- | -$0.53 | -$0.32 | -$0.21 |
| 03/19/2025 | Q4 | -- | -- | -$0.46 | -$0.40 | -$0.06 |
| 11/06/2024 | Q3 | -- | -- | -$0.38 | -$0.43 | $0.05 |
| 08/14/2024 | Q2 | -- | -- | -$0.40 | -$0.67 | $0.27 |
| 03/31/2024 | Q1 | -- | -- | -$3.53 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$84.29 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$9.62 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$7.53 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$6.50 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$3.09 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$3.13 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$3.42 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$3.39 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$2.29 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$1.76 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$2.19 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$2.38 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$7.66 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.41 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.16 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.02 | -- | -- |
LENZ Therapeutics, Inc. Earnings Questions
-
How Much did LENZ Therapeutics, Inc. Generate in Revenue Last Quarter?
LENZ Therapeutics, Inc. reported $12.5M worth of top line sales in its most recent quarter.
-
Did LENZ Therapeutics, Inc. Beat Earnings Last Quarter?
LENZ Therapeutics, Inc. announced earnings per share of -$0.59 which represents a beat of analyst forecast a -$0.69 per share.
-
Is LENZ Therapeutics, Inc. Profitable?
LENZ Therapeutics, Inc. reported $12.4M that represents $0.43 per share over the last quarter.
-
What is the Analyst Consensus for LENZ Therapeutics, Inc. EPS Next Year?
LENZ Therapeutics, Inc.'s earnings are forecast to decrease from -$2.34 per share to -$1.80 per share next year representing a decrease of -12.88%.
-
When is LENZ Therapeutics, Inc.'s Earnings Date?
LENZ Therapeutics, Inc.'s next earnings date is March 18, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
